Group One Trading, L.P. Avadel Pharmaceuticals PLC Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$9.64 - $14.59 $545,778 - $826,027	56,616 Added 915.67%	62,799 $886,000
Q3 2023 Nov 09, 2023	SELL	$10.3 - $15.99 $136,299 - $211,595	-13,233 Reduced 68.16%	6,183 $63,000
Q2 2023 Aug 09, 2023	SELL	$8.48 - $16.48 $793,312 - $1.54 Million	-93,551 Reduced 82.81%	19,416 $319,000
Q1 2023 May 12, 2023	BUY	$6.41 - $9.95 $553,118 - $858,585	86,290 Added 323.46%	112,967 $1.03 Million
Q4 2022 Feb 09, 2023	BUY	$5.02 - $10.0 $133,918 - $266,770	26,677 New	26,677 $191,000
Q2 2022 Aug 11, 2022	SELL	$1.07 - $6.95 $66,792 - $433,839	-62,423 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$5.46 - $8.29 $27,431 - $41,648	-5,024 Reduced 7.45%	62,423 $426,000
Q4 2021 Feb 11, 2022	BUY	$7.34 - $11.18 $4,103 - $6,249	559 Added 0.84%	67,447 $545,000
Q3 2021 Nov 12, 2021	BUY	$6.49 - $9.91 $434,103 - $662,860	66,888 New	66,888 $656,000
Q1 2021 May 12, 2021	SELL	$6.61 - $10.07 $139,556 - $212,607	-21,113 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$5.03 - $7.95 $127,409 - $201,373	-25,330 Reduced 54.54%	21,113 $141,000
Q3 2020 Nov 12, 2020	BUY	$5.02 - $8.98 $233,143 - $417,058	46,443 New	46,443 $234,000
Q3 2019 Nov 12, 2019	SELL	$1.92 - $4.47 $12,117 - $28,210	-6,311 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$1.09 - $3.19 $5,081 - $14,871	4,662 Added 282.72%	6,311 $18,000
Q1 2019 May 13, 2019	SELL	$1.44 - $3.29 $12,528 - $28,623	-8,700 Reduced 84.07%	1,649 $2,000
Q4 2018 Feb 06, 2019	SELL	$1.74 - $4.66 $26,331 - $70,519	-15,133 Reduced 59.39%	10,349 $27,000
Q3 2018 Nov 08, 2018	BUY	$4.08 - $7.14 $22,166 - $38,791	5,433 Added 27.1%	25,482 $112,000
Q2 2018 Aug 14, 2018	SELL	$5.89 - $7.78 $74,602 - $98,541	-12,666 Reduced 38.72%	20,049 $123,000
Q1 2018 May 11, 2018	BUY	$6.76 - $11.7 $162,956 - $282,040	24,106 Added 280.01%	32,715 $238,000
Q4 2017 Feb 09, 2018	BUY	$8.03 - $11.25 $69,130 - $96,851	8,609	8,609 $71,000

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account